376 related articles for article (PubMed ID: 8551492)
1. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
[TBL] [Abstract][Full Text] [Related]
3. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
4. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
Mallion JM; Goldberg AI
Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
[TBL] [Abstract][Full Text] [Related]
5. Losartan potassium as initial therapy in patients with severe hypertension.
Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
[TBL] [Abstract][Full Text] [Related]
6. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
7. Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. Danish Multicentre Group.
Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
J Hum Hypertens; 1995 Aug; 9(8):611-6. PubMed ID: 8523374
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
9. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
11. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life.
van Ree JW; van der Pol GA
J Hum Hypertens; 1996 Sep; 10(9):613-8. PubMed ID: 8953207
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of losartan.
Goldberg A; Sweet C
Can J Cardiol; 1995 Aug; 11 Suppl F():27F-32F. PubMed ID: 7664215
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group.
Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
J Hum Hypertens; 1995 Mar; 9 Suppl 1():S25-8. PubMed ID: 7783110
[TBL] [Abstract][Full Text] [Related]
14. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension.
Ogihara T; Yoshinaga K
Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545
[TBL] [Abstract][Full Text] [Related]
15. Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent.
Weber MA; Neutel JM; Smith DH
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S29-35. PubMed ID: 8583478
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
19. Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study Group.
Schaefer RM; Aldons PM; Burgess ED; Tilvis R; Girerd X; Singh GP; Rehn L; Morgan TO
Int J Clin Pract; 1998 Sep; 52(6):381-6. PubMed ID: 9894374
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Goldberg AI; Dunlay MC; Sweet CS
Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
